# Book Proposal Template

**Book Title:** Genomic Foundation Models: From Sequence to Clinical Insight
**Author:** [Your Name]
**Date:** [Submission Date]
**Submitted to:** [Publisher Name]

---

## 1. Book Overview

### Title and Subtitle

**Genomic Foundation Models: From Sequence to Clinical Insight**

*A Comprehensive Guide to Deep Learning Architectures for Genomic Data*

### Brief Description (250 words)

[Draft - customize per publisher]

The rapid emergence of foundation models is transforming genomic research and clinical practice. Large-scale pretrained models like DNABERT, Enformer, and ESM-2 now achieve state-of-the-art performance across tasks from variant effect prediction to protein function annotation. Yet no comprehensive resource exists for researchers navigating this fast-evolving landscape.

*Genomic Foundation Models* fills this gap. Written for graduate students and researchers at the intersection of machine learning and genomics, this textbook provides the conceptual foundations, architectural details, and practical guidance needed to understand, evaluate, and deploy genomic foundation models.

The book progresses from data fundamentals through modern architectures to clinical applications. Part I establishes genomic data foundations. Parts II-III cover deep learning architectures from convolutions through transformers. Parts IV-V survey foundation model families and cellular context models. Part VI addresses responsible deployment including uncertainty quantification, interpretability, and bias. Part VII demonstrates clinical translation from risk prediction to drug discovery.

With 32 chapters, 437 figures, and a 245-term glossary, this is the most comprehensive treatment of genomic foundation models available. Three reading pathways guide genomics researchers, ML practitioners, and clinical informaticists through material matched to their backgrounds.

### Extended Description (1000 words)

[Draft - expand from brief description]

Foundation models are reshaping genomics. Models pretrained on massive unlabeled sequence databases now power everything from GWAS fine-mapping to clinical variant interpretation. Yet the field moves so rapidly that practitioners struggle to evaluate competing approaches, understand architectural tradeoffs, and deploy models responsibly.

This textbook provides the comprehensive foundation that researchers and clinicians need...

[Continue with detailed chapter-by-chapter value proposition]

---

## 2. Target Audience

### Primary Audiences

**1. Graduate Students in Computational Biology/Bioinformatics**
- Course enrollment: 500+ programs globally offering computational biology degrees
- Need: Comprehensive textbook covering modern deep learning for genomics
- Current gap: Existing texts either predate foundation models or lack genomic depth

**2. Machine Learning Researchers Entering Genomics**
- Population: Growing number of CS/ML researchers applying methods to biology
- Need: Genomic domain knowledge paired with familiar ML concepts
- Current gap: No bridge text connecting ML foundations to genomic applications

**3. Clinical Informaticists and Lab Directors**
- Population: Clinical genomics labs adopting ML-based variant interpretation
- Need: Understanding of foundation model strengths, limitations, and deployment considerations
- Current gap: No clinically-grounded treatment of modern genomic ML

### Secondary Audiences

- Pharmaceutical industry researchers in drug discovery and target identification
- Biotech professionals working on sequence design and protein engineering
- Regulatory scientists evaluating AI-based diagnostics

### Reading Pathways

The book provides three structured reading pathways:

1. **Genomics Researchers:** Parts I (skim), II-IV (focus), V-VII (selective)
2. **ML Practitioners:** Parts I (foundations), II-IV (deep dive), V-VII (applications)
3. **Clinical Audience:** Part I (context), Parts III-IV (selected), Parts VI-VII (focus)

---

## 3. Competitive Analysis

### Existing Books

| Title | Author(s) | Year | Gap |
|-------|-----------|------|-----|
| *Deep Learning* | Goodfellow et al. | 2016 | No genomics application |
| *Bioinformatics and Functional Genomics* | Pevsner | 2015 | Pre-deep learning era |
| *Machine Learning in Genomics* | Various | 2020+ | Predates foundation models; fragmented |
| *Statistical Methods in Bioinformatics* | Ewens & Grant | 2005 | Statistical focus; no DL |

### Differentiation

1. **First comprehensive foundation model textbook** - No existing text covers genomic FMs at depth
2. **Cross-disciplinary bridge** - Equally accessible to ML and genomics audiences
3. **Clinical grounding** - Unique focus on deployment, uncertainty, and responsible AI
4. **Pedagogical design** - Learning objectives, glossary, multiple reading pathways
5. **Production-aligned** - Companion code repository with working examples

### Market Timing

Foundation models achieved breakthrough results in 2023-2025. Academic programs are adding courses on AI for biology. Clinical labs are evaluating FM-based tools. Market demand is high and accelerating.

---

## 3a. Foreword Commitment

### High-Profile Foreword Author

**Confirmed availability:** Dr. Matthew Callstrom, M.D., Ph.D.

The author has secured commitment from **Dr. Matthew Callstrom** to write the foreword for this book.

**About Dr. Callstrom:**
- **Chair, Department of Radiology** at Mayo Clinic (Rochester)
- **Medical Director, Generative Artificial Intelligence Program** at Mayo Clinic
- **Member, Mayo Clinic Board of Governors and Board of Trustees**
- Associate Medical Director, Strategy Department
- Over 20 years as Mayo Clinic consultant; 180+ publications and patents
- Leading Mayo's initiative to deploy ~100 AI algorithms with 270+ in development
- Ph.D. Chemistry (Minnesota), Postdoctoral Fellow (Harvard under Whitesides), M.D. (Mayo)

**Strategic significance:**
- Dr. Callstrom is a key figure in Mayo's AI strategy and on the short-list for future Mayo Clinic CEO
- His involvement signals institutional validation from one of the world's premier medical centers
- Quote from Dr. Callstrom: *"We're building AI into the fabric of Mayo"*

**Value to publisher:**
- Immediate credibility signal for clinical and academic markets
- Marketing asset for clinical informatics and radiology audiences
- Validation of clinical deployment content (Parts VI-VII)
- Cross-over appeal to healthcare AI market beyond genomics
- Mayo Clinic brand association

**Foreword scope:** Expected to address the transformation of clinical medicine through AI, Mayo's experience deploying AI at scale, and the critical need for rigorous educational resources bridging computational methods and clinical practice

---

## 4. Table of Contents

### Structure

**7 Parts, 32 Chapters, 6 Appendices**
**Estimated length:** ~340,000 words

### Part I: Data Foundations (Chapters 1-4)

| Ch | Title | Words | Description |
|----|-------|-------|-------------|
| 1 | From Reads to Variants | ~12,000 | Sequencing, alignment, variant calling fundamentals |
| 2 | Data Landscape | ~10,000 | Key datasets: gnomAD, ClinVar, ENCODE, UK Biobank |
| 3 | GWAS and Polygenic Scores | ~11,000 | Association studies, PRS, portability challenges |
| 4 | Classical Variant Prediction | ~9,000 | CADD, REVEL, conservation-based methods |

### Part II: Sequence Architectures (Chapters 5-7)

| Ch | Title | Words | Description |
|----|-------|-------|-------------|
| 5 | Tokens and Embeddings | ~8,000 | Sequence representations, tokenization strategies |
| 6 | Convolutional Networks | ~10,000 | DeepSEA, SpliceAI, regulatory prediction |
| 7 | Transformers and Attention | ~12,000 | Self-attention, position encoding, efficiency |

### Part III: Learning and Evaluation (Chapters 8-13)

| Ch | Title | Words | Description |
|----|-------|-------|-------------|
| 8 | Pretraining Strategies | ~10,000 | MLM, autoregressive, multi-task objectives |
| 9 | Transfer and Adaptation | ~9,000 | Fine-tuning, probing, domain shift |
| 10 | Feature Aggregation | ~8,000 | Pooling, attention aggregation, MI learning |
| 11 | Benchmarks | ~10,000 | Benchmark landscape, construction, limitations |
| 12 | Evaluation Principles | ~11,000 | Metrics, splitting strategies, calibration |
| 13 | Confounders and Leakage | ~12,000 | Ancestry bias, batch effects, label noise |

### Part IV: Foundation Model Families (Chapters 14-18)

| Ch | Title | Words | Description |
|----|-------|-------|-------------|
| 14 | Foundation Model Paradigm | ~10,000 | Defining FMs, scaling laws, taxonomy |
| 15 | DNA Language Models | ~14,000 | DNABERT, Nucleotide Transformer, HyenaDNA |
| 16 | Protein Language Models | ~12,000 | ESM family, structural awareness, variant effects |
| 17 | Regulatory Models | ~11,000 | Enformer, Borzoi, long-range interactions |
| 18 | Variant Effect Prediction | ~13,000 | FM-based VEP, integration, clinical mapping |

### Part V: Cellular Context (Chapters 19-23)

| Ch | Title | Words | Description |
|----|-------|-------|-------------|
| 19 | RNA Structure and Function | ~9,000 | RNA-FM, splicing, codon optimization |
| 20 | Single-Cell Models | ~10,000 | Geneformer, scBERT, perturbation prediction |
| 21 | 3D Genome Organization | ~8,000 | Chromatin folding, TAD prediction |
| 22 | Graph and Network Models | ~9,000 | GNNs, biological networks, knowledge graphs |
| 23 | Multi-Omics Integration | ~10,000 | Cross-modal learning, clinical integration |

### Part VI: Responsible Deployment (Chapters 24-27)

| Ch | Title | Words | Description |
|----|-------|-------|-------------|
| 24 | Uncertainty Quantification | ~12,000 | Calibration, ensembles, conformal prediction |
| 25 | Interpretability | ~11,000 | Attribution, attention analysis, probing |
| 26 | Causality and Intervention | ~9,000 | Causal inference, perturbation studies |
| 27 | Regulatory Frameworks | ~8,000 | FDA guidance, validation requirements |

### Part VII: Applications and Frontiers (Chapters 28-32)

| Ch | Title | Words | Description |
|----|-------|-------|-------------|
| 28 | Clinical Risk Prediction | ~11,000 | PRS-to-FM, EHR integration, deployment |
| 29 | Rare Disease Diagnosis | ~10,000 | Variant prioritization, ACMG integration |
| 30 | Drug Discovery | ~10,000 | Target identification, binding prediction |
| 31 | Sequence Design | ~9,000 | Protein design, regulatory optimization |
| 32 | Ethics and Frontiers | ~8,000 | Fairness, privacy, future directions |

### Appendices

| App | Title | Description |
|-----|-------|-------------|
| A | Deep Learning Primer | Background for readers without DL experience |
| B | Compute Requirements | GPU/TPU guidance for training and inference |
| C | Data Curation | Best practices for genomic dataset preparation |
| D | Model Reference Table | Summary table of major foundation models |
| E | Resources | Datasets, tools, code repositories |
| F | Glossary | 245 key terms with definitions |

---

## 5. Sample Chapters

[Attach 2-3 polished sample chapters]

**Recommended samples:**
- Chapter 5: Tokens and Embeddings (accessible entry point)
- Chapter 7: Transformers and Attention (technical depth)
- Chapter 14: Foundation Model Paradigm (central thesis)

---

## 6. Author Information

### Biography

[Your professional bio - 150-300 words]

### Qualifications

- [Current position and institution]
- [Relevant degrees and training]
- [Research focus areas]
- [Publication track record]

### Platform

- Institutional affiliation: [Institution]
- Web presence: gfm.meehl.org (book web version)
- Conference participation: [ASHG, ISMB, NeurIPS, etc.]
- Teaching experience: [Relevant courses]

---

## 7. Production Details

### Manuscript Status

- **Current state:** Content-complete draft
- **Word count:** ~340,000 words
- **Chapters:** 32 + 6 appendices
- **Figures:** 437 (SVG format; high-resolution available)
- **References:** 359 citations

### Timeline

- **Manuscript polish:** 4-6 weeks from contract
- **Final submission:** [Target date]

### Technical Requirements

- Mathematical notation: LaTeX-style equations
- Code blocks: Python, R (syntax highlighted)
- Figures: Vector SVG; can provide 300+ DPI raster

### Supplementary Materials

- Companion code repository (GitHub)
- Web version at gfm.meehl.org
- Jupyter notebooks for key examples

---

## 8. Market Analysis

### Course Adoption Potential

**Target courses:**
- Computational Genomics (graduate)
- Machine Learning for Biology (graduate)
- Clinical Bioinformatics (professional)
- Deep Learning Applications (graduate)

**Sample programs:**
- MIT Computational and Systems Biology
- Stanford Biomedical Informatics
- Johns Hopkins Computational Biology
- UCSD Bioinformatics
- [Add 10+ more programs]

### Professional Market

- Clinical genomics laboratories adopting ML tools
- Pharmaceutical companies with genomics platforms
- Biotech startups in sequence design space

### International Reach

Foundation model adoption is global. Key markets:
- North America (US, Canada)
- Europe (UK, Germany, Netherlands)
- Asia (China, Singapore, Japan)

---

## 9. Requested Terms

### Open Access

Request right to maintain existing web version at gfm.meehl.org alongside print publication. Evidence suggests open access drives print sales for technical textbooks.

### Code Repository

Request right to maintain open-source companion code repository.

### Derivative Works

Request right to create course materials, tutorials, and workshops based on book content.

---

## 10. Initial Inquiry Templates

Per MIT Press guidelines, initial inquiries should be brief (few paragraphs) without attachments. Only send full proposals when invited.

---

### Template A: MIT Press (Janice Audet - Biomedical Science)

**Subject:** Book Proposal Inquiry: Genomic Foundation Models

Dear Ms. Audet,

I am writing to inquire about MIT Press's interest in publishing *Genomic Foundation Models: From Sequence to Clinical Insight*, a comprehensive graduate-level textbook at the intersection of deep learning and clinical genomics.

Foundation models—large-scale pretrained neural networks like DNABERT, ESM-2, and Enformer—are transforming how we interpret genomic variation and predict disease risk. Yet no comprehensive educational resource exists for this rapidly growing field. My manuscript fills this gap, bridging computational methodology and clinical application.

**About the book:**
- Content-complete at ~340,000 words across 32 chapters (7 parts)
- Three structured reading pathways for genomics, ML, and clinical audiences
- Part VI covers responsible deployment (uncertainty, interpretability, fairness)
- Part VII addresses clinical translation (risk prediction, rare disease diagnosis, drug discovery)
- Dr. Matthew Callstrom, Mayo Clinic's Medical Director for Generative AI and Board of Governors member, has agreed to write the foreword
- A web version at gfm.meehl.org demonstrates community interest

**About me:**
[Your credentials, affiliation, relevant publications]

I believe this work aligns well with MIT Press's strength in biomedical science and trade science. I would welcome the opportunity to discuss a full proposal.

Sincerely,
[Your Name]
[Contact information]

---

### Template B: Cambridge University Press (Megan Keirnan - Life Sciences)

**Subject:** Computational Biology Textbook Proposal: Genomic Foundation Models

Dear Megan,

I am reaching out regarding a graduate textbook project that I believe aligns well with your computational biology list: *Genomic Foundation Models: From Sequence to Clinical Insight*.

This book provides the first comprehensive treatment of foundation models for genomic data—covering architectures (transformers, state-space models), model families (DNA language models, protein language models, regulatory models), and clinical applications (variant effect prediction, risk assessment, drug discovery).

**Key features:**
- 32 chapters (~340,000 words) organized into 7 thematic parts
- Designed for graduate courses in computational genomics and ML for biology
- Three reading pathways for different backgrounds (genomics, ML, clinical)
- 437 figures, 245-term glossary, 359 references
- Foreword commitment from Mayo Clinic's AI leadership (Dr. Matthew Callstrom, Medical Director for Generative AI)
- Companion web version live at gfm.meehl.org

The manuscript is content-complete. I would welcome guidelines for preparing a full proposal tailored to Cambridge's requirements.

Best regards,
[Your Name]
[Affiliation]
[Contact information]

---

### Template C: Generic Cover Letter (for full proposal)

Dear [Editor Name],

I am pleased to submit a full proposal for *Genomic Foundation Models: From Sequence to Clinical Insight* for consideration by [Publisher].

[Per initial inquiry discussion / As we discussed...]

Foundation models are transforming genomic research and clinical practice, yet no comprehensive textbook exists for this rapidly growing field. This manuscript provides graduate students and researchers with the conceptual foundations, architectural details, and practical guidance they need.

**Enclosed materials:**
- Book overview and rationale
- Annotated table of contents
- Sample chapters (Introduction, Chapter 7: Transformers and Attention, Chapter 14: Foundation Model Paradigm)
- Competitive analysis
- Author CV
- Foreword author confirmation (Dr. Matthew Callstrom, Mayo Clinic)

The manuscript is content-complete at approximately 340,000 words. I believe [Publisher]'s strength in [specific area] makes it the ideal home for this work.

I would welcome the opportunity to discuss this project further.

Sincerely,
[Your Name]
[Contact information]

---

## Appendix: Endorsement Requests

[Track outreach for potential endorsements]

| Name | Affiliation | Status | Response |
|------|-------------|--------|----------|
| [Name] | [Institution] | Not contacted | |
| [Name] | [Institution] | Not contacted | |
| [Name] | [Institution] | Not contacted | |

---

## Related Documents

- [Publishing Strategy](./publishing-strategy.md)
- [Pre-Submission Checklist](./pre-submission-checklist.md)
- [Publisher Comparison](./publisher-comparison.md)
